New Home2026-05-21T14:39:16+10:00

Transform Your Response

Transform Your Response

Patient-Led. Built From Lived Experience.

Learn to keep options open.

Keep options open

Where Patients Lose

The Patient Survival System

Biliary 101

Why This Foundation Exists

I am a late-stage 4 cholangiocarcinoma survivor and co-founder of Cholangiocarcinoma Foundation Australia alongside my wife, Claire.

What most patients need in that moment is not reassurance alone.

They need orientation.
What matters now.
What comes next.

That is why this Foundation exists.

Everything we build is designed around one goal:

Improving today’s patient survival – today.

View my bio

Just yesterday, I was a person. Today, I am a patient.
I must become the best patient I can be, so that I can become that person again.

Steve

Our People Our Community Our Culture

2511, 2017

Bayer enters the immunotherapy race

By |

Bayer joins in . . .Loxo is trying to repeat the trick achieved by Merck & Co (known as MSD outside the US and Canada) when it secured approval for PD1 inhibitor Keytruda (pembrolizumab) for all cancers, regardless of location in the body

Testimonials

Go to Top